Search research articles
Contact Us
Filters
Showing results (111-120 of 141) with videos related to
Page
of 15
Sort By:
Frontiers in Medicine
|
October 2, 2024
Evaluation of the review models and approval timelines of authorities participating in the East African Medicine Regulatory Harmonisation initiative: alignment and strategies for moving forward
Nancy Ngum, Margareth Ndomondo-Sigonda, Rémy Habonimana, et al.
Frontiers in Medicine
|
September 13, 2024
Evaluation of good review practices in member authorities of the East African Medicines Regulatory Harmonisation initiative: strategies for alignment with African medicines agency
Nancy Ngum, Margareth Ndomondo-Sigonda, Rémy Habonimana, et al.
Therapeutic Innovation & Regulatory Science
|
October 27, 2025
Regulatory Performance of African National Medicines Regulatory Authorities Achieving WHO Maturity Level 3: Identifying Best Practices
Mercy Owusu-Asante, Delese Mimi Darko, Boitumelo Semete-Makokotieia, et al.
Journal of Patient-Reported Outcomes
|
November 9, 2023
Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial
David A Andrae, Rachael F Grace, Adrian Jewett, et al.
Journal of Patient-Reported Outcomes
|
April 29, 2025
Translation, cultural adaptation and validation of the Danish version of the haematological malignancy patient-reported outcome measure (HM-PRO)
Sam Salek, Sören Möller, Niels Abildgaard, et al.
Frontiers in Medicine
|
June 12, 2026
Development and validation of an artificial intelligence proof-of-concept tool for risk-based quality assessment of generic medicines: a South African case study
Lorraine Danks, Boitumelo Semete-Makokotlela, Christelna Reynecke, et al.
Future Oncology (London, England)
|
November 16, 2025
ALIDHE phase 3b study design: ivosidenib + azacitidine in adults with newly diagnosed <i>IDH1</i> mutant acute myeloid leukemia
Paresh Vyas, Sam Salek, Susana Vives, et al.
Future Oncology (London, England)
|
November 19, 2025
Patient involvement in the design of ALIDHE: a study of ivosidenib + azacitidine in newly diagnosed <i>IDH1</i> mutant AML
Samantha Nier, Jana Pelouchova, Ralph Hills, et al.
Multiple Sclerosis and Related Disorders
|
July 13, 2021
Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 - Fatigue (MS) 8a
Paul Kamudoni, Jeffrey Johns, Karon F Cook, et al.
Frontiers in Medicine
|
September 13, 2021
Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward
Tariro Sithole, Gugu Mahlangu, Velma Capote, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 141) with videos related to
Sort By:
Page
of 15
Frontiers in Medicine
|
October 2, 2024
Evaluation of the review models and approval timelines of authorities participating in the East African Medicine Regulatory Harmonisation initiative: alignment and strategies for moving forward
Nancy Ngum, Margareth Ndomondo-Sigonda, Rémy Habonimana, et al.
Frontiers in Medicine
|
September 13, 2024
Evaluation of good review practices in member authorities of the East African Medicines Regulatory Harmonisation initiative: strategies for alignment with African medicines agency
Nancy Ngum, Margareth Ndomondo-Sigonda, Rémy Habonimana, et al.
Therapeutic Innovation & Regulatory Science
|
October 27, 2025
Regulatory Performance of African National Medicines Regulatory Authorities Achieving WHO Maturity Level 3: Identifying Best Practices
Mercy Owusu-Asante, Delese Mimi Darko, Boitumelo Semete-Makokotieia, et al.
Journal of Patient-Reported Outcomes
|
November 9, 2023
Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial
David A Andrae, Rachael F Grace, Adrian Jewett, et al.
Journal of Patient-Reported Outcomes
|
April 29, 2025
Translation, cultural adaptation and validation of the Danish version of the haematological malignancy patient-reported outcome measure (HM-PRO)
Sam Salek, Sören Möller, Niels Abildgaard, et al.
Frontiers in Medicine
|
June 12, 2026
Development and validation of an artificial intelligence proof-of-concept tool for risk-based quality assessment of generic medicines: a South African case study
Lorraine Danks, Boitumelo Semete-Makokotlela, Christelna Reynecke, et al.
Future Oncology (London, England)
|
November 16, 2025
ALIDHE phase 3b study design: ivosidenib + azacitidine in adults with newly diagnosed <i>IDH1</i> mutant acute myeloid leukemia
Paresh Vyas, Sam Salek, Susana Vives, et al.
Future Oncology (London, England)
|
November 19, 2025
Patient involvement in the design of ALIDHE: a study of ivosidenib + azacitidine in newly diagnosed <i>IDH1</i> mutant AML
Samantha Nier, Jana Pelouchova, Ralph Hills, et al.
Multiple Sclerosis and Related Disorders
|
July 13, 2021
Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 - Fatigue (MS) 8a
Paul Kamudoni, Jeffrey Johns, Karon F Cook, et al.
Frontiers in Medicine
|
September 13, 2021
Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward
Tariro Sithole, Gugu Mahlangu, Velma Capote, et al.
Page
of 15